Birner Hubert

CIK 00013985987 companiesNORTHBROOK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001398598

Recent Transactions

50 trades

Purchase
Acer Therapeutics Inc.
Common Stock
2018-08-01$18.00/sh+275,000→ 1,697,709 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2018-06-08+12,700→ 12,700 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+1,172,709→ 1,172,709 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+663,782→ 663,782 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+227,485→ 227,485 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+372→ 500 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+128→ 500 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+372→ 500 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2017-06-20+6,666→ 6,666 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2017-01-19+9,500→ 9,500 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-12-31+3,571→ 12,680 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-09-30+3,521→ 9,109 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-06-30+2,854→ 5,588 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock Warrants (right to buy)
2016-06-29+206,659→ 206,659 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2016-06-29+275,545→ 1,930,333 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2016-06-13+5,500→ 5,500 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2016-06-09+6,666→ 6,666 total
Award
ARGOS THERAPEUTICS INC
Common Stock
2016-03-31+2,734→ 2,734 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock
2016-03-14+183,697→ 1,654,788 total
Purchase
ARGOS THERAPEUTICS INC
Common Stock Warrants (right to buy)
2016-03-14+137,773→ 137,773 total
Award
ARGOS THERAPEUTICS INC
Stock Option (right to buy)
2015-06-17+5,500→ 5,500 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2015-06-02+6,666→ 6,666 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+223,410→ 223,410 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+379,462→ 1,786,616 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Warrants (Right to Buy)
2014-10-27−39,932→ 0 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−451,276→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−1,277,663→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series C Convertible Preferred Stock
2014-10-27−2,331,391→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series B Convertible Preferred Stock
2014-10-27−2,436,618→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$4.60/sh+116,511→ 1,903,127 total
Conversion
Protara Therapeutics, Inc.$TARA
Series C Convertible Preferred Stock
2014-10-27−799,043→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series B Convertible Preferred Stock
2014-10-27−835,121→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A-1 Convertible Preferred Stock
2014-10-27−717,260→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$4.60/sh+39,932→ 1,943,059 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2014-10-27−4,468,482→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+1,107,154→ 1,407,154 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+76,590→ 300,000 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A-1 Convertible Preferred Stock
2014-10-27−2,092,735→ 0 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−1,316,683→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Warrants (Right to Buy)
2014-10-27−116,511→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−3,727,823→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2014-10-27−1,531,518→ 0 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−274,880→ 1,178,534 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−66,506→ 285,129 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−88,877→ 381,052 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−66,506→ 276,999 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−88,877→ 370,187 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−274,880→ 1,144,932 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−1,402→ 351,635 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−5,795→ 1,453,414 total

Companies

Recent Filings

Address

C/O HORIZON PHARMA, INC. 1033 SKOKIE BLVD., SUITE 355

NORTHBROOK, IL, 60062

View on SEC.gov